Výsledky vyhledávání

Akademický článek

Non pharmacological treatments in fibromyalgia

Publikováno v: Reumatismo, Vol 60, Iss 1s, Pp 59-69 (2011)

To fully answer the complex question of what modes of non pharmacological treatments are useful for fibromyalgia (FM) one should ask different layers of questions, and as with peeling layers of onions, be prepared to shed some tears. The first painfu

Externí odkaz: https://doaj.org/article/33cba35092b24f3783910d3de3fcb1a5

Zobrazit plný text záznamu

Akademický článek

Symptoms and signs in fibromyalgia syndrome

Publikováno v: Reumatismo, Vol 60, Iss 1s, Pp 15-24 (2011)

Fibromyalgia (FM) is currently classified as chronic widespread pain with widespread allodynia/hyperalgesia to pressure pain and is categorized among the large group of soft-tissue pain syndromes. FM remains an elusive condition of unknown etiology i

Externí odkaz: https://doaj.org/article/989b7bdd997e442c9ab8638fc8a0fde6

Zobrazit plný text záznamu

Akademický článek

Fibromyalgia syndrome: the pharmacological treatment options

Publikováno v: Reumatismo, Vol 60, Iss 1s, Pp 50-58 (2011)

Fibromyalgia (FM), also known as fibromyalgia syndrome (FMS), is a frequently observed systemic disorder characterized by widespread musculoskeletal pain (1, 2). Its prevalence in the general population is 1-3%, and it is more common among females th

Externí odkaz: https://doaj.org/article/d1ac981c3af24c42bc079a4f1d4fe3fa

Zobrazit plný text záznamu

Akademický článek

Fibromyalgia syndrome: preventive, social and economic aspects

Publikováno v: Reumatismo, Vol 60, Iss 1s, Pp 70-77 (2011)

Fibromyalgia (FM) is a central pain syndrome that is characterized, in part, by specific tender points (TPs) in the musculoskeletal system which are exceptionally sensitive to pressure. Pain, specifically characterized as hyperalgesia and allodynia,

Externí odkaz: https://doaj.org/article/3805e84cdc894f7ca67fdad85baf67b6

Zobrazit plný text záznamu

Akademický článek

Etiopathogenetic mechanisms of fibromyalgia syndrome

Autor: R.H. Gracely, R. Carignola, L. Bazzichi, F. Ceccherelli, M. Marsico, R. Gorla, G. Leardini, A. Alciati, G. Arioli, P. Sarzi-Puttini, M.A. Giamberardino, M. Spath, D. Buskila, M. Cazzola, S. Stisi, F. Salaffi, L. Altomonte, F. Atzeni

Publikováno v: Reumatismo, Vol 60, Iss 1s, Pp 25-35 (2011)

Fibromyalgia syndrome (FMS) is a common chronic condition of widespread pain with causal mechanisms that are largely unknown. It is characterized by moderate to severe musculoskel - etal pain and allodynia, but its pathogenesis appears confined to th

Externí odkaz: https://doaj.org/article/19d979fa179e4796956f581b62a6141f

Zobrazit plný text záznamu

Akademický článek

The evaluation of the fibromyalgia patients

Publikováno v: Reumatismo, Vol 60, Iss 1s, Pp 36-49 (2011)

Fibromyalgia (FM) is a rheumatic disease characterized by musculoskeletal pain, chronic diffuse tension and/or stiffness from joints and muscles, easy fatigue, sleep and emotional disturbances, and pressure pain sensitivity in at least 11 of 18 tende

Externí odkaz: https://doaj.org/article/4d6d1fc6e1094428a312f7ac442730a1

Zobrazit plný text záznamu

Akademický článek

Anti-TNFα agents in elderly patients with rheumatoid arthritis: a study of a group of 105 over sixty five years old patients

Autor: C. Biasini Rebaioli, M. Vianelli, M. Nuzzo, T. Ziglioli, S. Zingarelli, C. Bazzani, M. Filippini, R. Cattaneo, R. Gorla

Publikováno v: Reumatismo, Vol 60, Iss 1, Pp 41-49 (2011)

Objective: To evaluate the efficacy and the safety of anti-TNF-alfa treatment in elderly patients (≥65 years old) with active rheumatoid arthritis (RA), in comparison with younger (17-65 years old). Methods: We considered retrospectively 295 patien

Externí odkaz: https://doaj.org/article/2dd11d73367c4688b0c0b02b4fe09865

Zobrazit plný text záznamu

Akademický článek

Efficacy and safety of anti-TNF agents in the Lombardy rheumatoid arthritis network (LORHEN)

Autor: R. Caporali, M. Filippini, R. Gorla, E.G. Favalli, A. Marchesoni, M. Antivalle, P. Sarzi- Puttini, F. Bobbio-Pallavicini, C. Montecucco, F. Atzeni

Publikováno v: Reumatismo, Vol 60, Iss 4, Pp 290-295 (2011)

Clinical trials have shown that anti-tumour necrosis factor (TNF)-α drugs are effective in patients with rheumatoid arthritis (RA) refractory to disease- modifying antirheumatic drugs (DMARDs) (1-4). At about the same time as the European approval o

Externí odkaz: https://doaj.org/article/a3e6e4291560442c8293fdb98392bc26

Zobrazit plný text záznamu

Akademický článek

Early rheumatoid arthritis: a prospective study on how to induce the remission

Autor: S. Zingarelli, M. Filippini, C. Bazzani, T. Ziglioli, A. Giugno, R. Gorla

Publikováno v: Reumatismo, Vol 60, Iss 2, Pp 131-135 (2011)

Objectives: To investigate whether the aggressive use of DMARDs can control the clinical disease in the early arthritis, to define new parameters of the disease aggressivity and to study the effectiveness of RMN in comparison with RX focusing on the

Externí odkaz: https://doaj.org/article/d7f0a0295ae14d4b8aa1cbf2b4ab2e1d

Zobrazit plný text záznamu

Akademický článek

Fibromyalgia syndrome: definition and diagnostic aspects

Publikováno v: Reumatismo, Vol 60, Iss 1s, Pp 3-14 (2011)

Although the term “fibromyalgia” (FM) is relatively new, the condition characterised by chronic musculoskeletal pain that is accompanied by numerous extra-skeletal symptoms has been described in the medical literature for many years under differe

Externí odkaz: https://doaj.org/article/d6a0615a0c7747b1be6d48b2fda05ae9

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání